# Organ-on-Chip Analysis Agent

**ID:** `biomedical.drug_discovery.organ_on_chip`
**Version:** 1.0.0
**Status:** Experimental
**Category:** Drug Discovery / Safety Pharmacology

---

## Overview

The **Organ-on-Chip Analysis Agent** processes and analyzes data from microphysiological systems (MPS) and organ-on-chip (OoC) devices for drug safety assessment. These advanced in vitro platforms provide more physiologically relevant toxicity data than traditional 2D cell culture, bridging the gap between in vitro and in vivo studies.

This agent integrates data from multi-organ chips, applies AI analysis to complex readouts, and correlates findings with clinical outcomes to improve translational predictivity.

---

## Key Capabilities

### 1. Supported Organ Models

| Organ Chip | Readouts | Applications |
|------------|----------|--------------|
| **Liver-on-Chip** | Albumin, urea, bile acids, CYP activity | Hepatotoxicity, drug metabolism |
| **Heart-on-Chip** | Contractility, beat rate, field potential | Cardiotoxicity, arrhythmia |
| **Kidney-on-Chip** | GFR, albumin leakage, transporter activity | Nephrotoxicity |
| **Lung-on-Chip** | Barrier integrity, surfactant, inflammation | Pulmonary toxicity |
| **Gut-on-Chip** | Permeability, TEER, microbiome | Absorption, GI toxicity |
| **Brain-on-Chip** | BBB permeability, neuronal activity, glia | Neurotoxicity |

### 2. Multi-Organ Integration

- **Body-on-Chip:** Connected organ systems with circulating media
- **PK modeling:** Physiologically-based compartmental analysis
- **Metabolite tracking:** Inter-organ metabolite transfer
- **Systemic toxicity:** Whole-body effect prediction

### 3. Data Analysis Capabilities

| Analysis Type | Method | Output |
|---------------|--------|--------|
| **Time-series analysis** | Dynamic modeling | Toxicity kinetics |
| **Dose-response** | Hill equation fitting | EC50, IC50 |
| **Viability scoring** | Multi-parametric | Composite toxicity index |
| **Image analysis** | Deep learning | Morphological changes |
| **Electrophysiology** | Signal processing | Cardiac/neural activity |

### 4. Clinical Translation

- **IVIVE:** In vitro to in vivo extrapolation
- **Human relevance:** Species comparison
- **Biomarker correlation:** Clinical endpoint prediction
- **Regulatory support:** FDA/EMA guideline compliance

---

## Usage

### Example Prompt

```text
Analyze hepatotoxicity data from a liver-on-chip experiment.
Test compound: Acetaminophen
Concentrations: 0, 10, 100, 500, 1000, 5000 μM
Timepoints: 24h, 48h, 72h

Readouts:
- Cell viability (ATP)
- Albumin secretion
- Urea production
- LDH release
- CYP3A4 activity

Determine the toxic threshold and compare to clinical Cmax.
```

### Expected Output

```
## Liver-on-Chip Hepatotoxicity Analysis

### Compound: Acetaminophen (APAP)
- **Clinical Cmax:** ~140 μM (therapeutic dose)
- **Toxic threshold (clinical):** >1000 μM (overdose)

### Viability Analysis (72h endpoint)

| Concentration (μM) | ATP (% control) | LDH Release (fold) | Status |
|--------------------|-----------------|--------------------| ------|
| 0 | 100 ± 5 | 1.0 ± 0.1 | Control |
| 10 | 98 ± 4 | 1.0 ± 0.1 | No effect |
| 100 | 95 ± 6 | 1.1 ± 0.2 | No effect |
| 500 | 82 ± 8 | 1.8 ± 0.3 | Mild toxicity |
| 1000 | 54 ± 12 | 3.2 ± 0.5 | Moderate toxicity |
| 5000 | 12 ± 6 | 8.4 ± 1.2 | Severe toxicity |

### Dose-Response Curve (ATP viability)
```
IC50 = 890 μM (95% CI: 720-1100 μM)
Hill coefficient = 1.8

Viability%
100|***
 80|    ***
 60|       ***
 40|          ***
 20|             ***
  0+-----|-----|-----|-----|----> Conc (μM)
        100   500  1000  5000
```

### Functional Readouts (Time Course)

#### Albumin Secretion (ng/mL/day)
| Timepoint | Control | 500 μM | 1000 μM |
|-----------|---------|--------|---------|
| 24h | 45 ± 5 | 42 ± 4 | 28 ± 6 |
| 48h | 48 ± 4 | 35 ± 5 | 18 ± 4 |
| 72h | 50 ± 5 | 30 ± 6 | 12 ± 3 |

**Interpretation:** Early albumin decline indicates hepatocyte function loss

#### CYP3A4 Activity (fold control)
| Concentration | 24h | 48h | 72h |
|---------------|-----|-----|-----|
| 500 μM | 0.9 | 0.7 | 0.5 |
| 1000 μM | 0.6 | 0.4 | 0.2 |

**Interpretation:** CYP3A4 inhibition precedes cell death (mechanism-based)

### Safety Margin Analysis

| Parameter | Value | Clinical Reference |
|-----------|-------|-------------------|
| **IC50 (liver chip)** | 890 μM | - |
| **Therapeutic Cmax** | 140 μM | Clinical PK |
| **Safety Margin** | 6.4x | >10x preferred |
| **Toxic Cmax (overdose)** | 1000+ μM | Case reports |

### IVIVE Translation

| In Vitro | In Vivo Prediction |
|----------|-------------------|
| IC50 = 890 μM | Hepatotoxicity onset ~6x therapeutic |
| Albumin ↓ at 500 μM | Subclinical injury possible at 3-4x Cmax |
| CYP inhibition early | Metabolite-mediated mechanism confirmed |

### Mechanism Analysis

```
APAP
  ↓ CYP2E1/CYP3A4
NAPQI (reactive metabolite)
  ↓ Glutathione depletion
Mitochondrial dysfunction
  ↓
Hepatocyte death (necrosis)
```

**Chip findings consistent with known mechanism:**
- Early CYP changes (metabolic activation)
- Delayed cell death (downstream of metabolite formation)
- LDH release pattern (necrotic death mode)

### Conclusion
The liver-on-chip accurately recapitulates acetaminophen hepatotoxicity
with an IC50 of 890 μM, providing a 6.4x safety margin over therapeutic
Cmax. This aligns with clinical experience where hepatotoxicity occurs
primarily in overdose settings. The early albumin and CYP changes could
serve as sensitive biomarkers for subclinical injury.
```

### LLM Agent Integration

```python
@tool
def analyze_organ_chip_data(
    organ_type: str,
    compound: str,
    concentrations: list[float],
    timepoints: list[str],
    readouts: dict
) -> str:
    """
    Analyzes organ-on-chip toxicity data.

    Args:
        organ_type: liver, heart, kidney, lung, gut, or brain
        compound: Test compound name or identifier
        concentrations: List of test concentrations (μM)
        timepoints: List of measurement timepoints
        readouts: Dictionary of readout data {name: values}

    Returns:
        Comprehensive analysis with dose-response and clinical translation
    """
    pass


@tool
def predict_clinical_toxicity(
    chip_ic50: float,
    clinical_cmax: float,
    organ: str,
    compound: str
) -> str:
    """
    Translates chip data to clinical toxicity prediction.

    Args:
        chip_ic50: IC50 from organ chip (μM)
        clinical_cmax: Clinical maximum concentration (μM)
        organ: Target organ
        compound: Compound name

    Returns:
        Clinical toxicity risk assessment
    """
    pass
```

---

## Prerequisites

### Required Equipment/Data Sources

| Resource | Purpose | Vendors |
|----------|---------|---------|
| **Liver chips** | Hepatotoxicity | Emulate, CN Bio, TissUse |
| **Cardiac chips** | Cardiotoxicity | Biowire, TARA |
| **Multi-organ chips** | Systemic toxicity | Hesperos, TissUse |
| **Imaging systems** | Morphology analysis | High-content microscopy |
| **MEA systems** | Electrophysiology | Axion, Multi Channel Systems |

### Dependencies

```
pandas>=1.5
numpy>=1.24
scipy>=1.10
scikit-learn>=1.3
matplotlib>=3.7
seaborn>=0.12
```

---

## Methodology

### Data Analysis Pipeline

```
Raw Chip Data
    ↓
Quality Control
    ├── Outlier detection
    ├── Normalization (to control wells)
    └── Batch correction
    ↓
Dose-Response Modeling
    ├── 4-parameter logistic fit
    ├── IC50/EC50 calculation
    └── Confidence intervals
    ↓
Time-Course Analysis
    ├── Kinetic modeling
    └── AUC calculation
    ↓
Multi-Parametric Integration
    ├── Principal component analysis
    ├── Toxicity index calculation
    └── Phenotype clustering
    ↓
Clinical Translation (IVIVE)
    ├── Safety margin calculation
    └── Risk assessment
```

### Dose-Response Fitting

```python
from scipy.optimize import curve_fit
import numpy as np

def four_parameter_logistic(x, bottom, top, ic50, hill):
    """4PL dose-response model."""
    return bottom + (top - bottom) / (1 + (x / ic50) ** hill)


def fit_dose_response(concentrations: np.ndarray, responses: np.ndarray) -> dict:
    """
    Fit dose-response curve and calculate IC50.
    """
    # Initial guesses
    p0 = [min(responses), max(responses), np.median(concentrations), 1.0]

    # Fit
    popt, pcov = curve_fit(
        four_parameter_logistic,
        concentrations,
        responses,
        p0=p0,
        bounds=([0, 0, 0, 0], [np.inf, np.inf, np.inf, 10])
    )

    # Calculate confidence intervals
    perr = np.sqrt(np.diag(pcov))

    return {
        'bottom': popt[0],
        'top': popt[1],
        'ic50': popt[2],
        'ic50_ci': (popt[2] - 1.96*perr[2], popt[2] + 1.96*perr[2]),
        'hill': popt[3]
    }
```

---

## Related Skills

- **Multi-Endpoint Toxicity Agent:** Computational toxicity prediction
- **Digital Twin Patient Agent:** Physiological modeling
- **Lab Automation (PyLabRobot):** Chip handling automation

---

## References

- **Ingber (2022):** "Human organs-on-chips for disease modelling, drug development and personalized medicine." *Nature Reviews Genetics*
- **Ewart et al. (2022):** "Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology." *Communications Medicine*
- [Emulate Organ-Chips](https://emulatebio.com/)
- [FDA MPS Guidelines](https://www.fda.gov/science-research/about-science-research-fda/microphysiological-systems)

---

## Author

**MD BABU MIA**
*Artificial Intelligence Group*
*Icahn School of Medicine at Mount Sinai*
md.babu.mia@mssm.edu
